Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
$0.81
-3.6%
$0.99
$0.72
$2.55
$1.74B1.4231.24 million shs31.41 million shs
Galapagos NV stock logo
GLPG
Galapagos
$29.63
+0.3%
$30.87
$28.30
$45.21
$1.95B0.27123,178 shs140,221 shs
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
$18.62
-2.6%
$24.18
$13.64
$28.35
$1.42B0.52694,312 shs699,530 shs
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
$25.76
-0.3%
$26.31
$24.77
$34.53
$2.31B1.071.00 million shs871,250 shs
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
-3.21%+6.28%-7.11%-44.99%-36.32%
Galapagos NV stock logo
GLPG
Galapagos
+0.27%+3.78%+1.40%-25.29%-28.79%
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
-2.56%-0.16%-22.32%-12.21%-5.34%
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
-0.35%+1.82%+0.12%-9.14%-4.66%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
1.7535 of 5 stars
2.81.00.00.02.34.20.6
Galapagos NV stock logo
GLPG
Galapagos
0.2659 of 5 stars
1.91.00.00.02.50.00.6
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
4.7348 of 5 stars
4.01.00.03.91.62.53.1
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
4.765 of 5 stars
4.13.03.31.71.81.71.9

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
1.67
Reduce$1.90134.94% Upside
Galapagos NV stock logo
GLPG
Galapagos
1.75
Reduce$34.5016.44% Upside
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
2.00
Hold$23.2925.06% Upside
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
2.25
Hold$32.5626.38% Upside

Current Analyst Ratings

Latest OMI, PDCO, GLPG, and DNA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/15/2024
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$2.00 ➝ $1.00
5/15/2024
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeNeutral ➝ Sell
5/10/2024
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeMarket Perform ➝ Underperform
5/6/2024
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$28.00 ➝ $24.00
4/30/2024
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$24.00 ➝ $28.00
4/26/2024
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetIn-Line ➝ In-Line$28.00 ➝ $27.00
4/22/2024
Galapagos NV stock logo
GLPG
Galapagos
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingEqual Weight ➝ Equal Weight$38.00 ➝ $38.00
4/10/2024
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$24.00 ➝ $28.00
3/28/2024
Galapagos NV stock logo
GLPG
Galapagos
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Underperform$41.00 ➝ $31.00
3/7/2024
Galapagos NV stock logo
GLPG
Galapagos
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageEqual Weight$38.00
3/6/2024
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$31.00 ➝ $30.00
(Data available from 5/18/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
$251.46M6.92N/AN/A$0.46 per share1.76
Galapagos NV stock logo
GLPG
Galapagos
$259.40M7.53$0.66 per share44.66$47.70 per share0.62
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
$10.33B0.14$4.73 per share3.94$11.70 per share1.59
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
$6.47B0.36$3.27 per share7.88$11.45 per share2.25

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
-$892.87M-$0.44N/AN/AN/A-409.11%-56.09%-35.89%8/14/2024 (Estimated)
Galapagos NV stock logo
GLPG
Galapagos
$229.12MN/A0.00N/AN/A-26.25%-2.60%-1.46%8/1/2024 (Estimated)
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
-$41.30M-$0.51N/A9.700.68-0.37%12.97%2.26%8/2/2024 (Estimated)
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
$207.56M$2.0312.6910.391.272.95%20.98%7.70%6/19/2024 (Estimated)

Latest OMI, PDCO, GLPG, and DNA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2024Q1 2024
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
-$0.08-$0.08N/A-$0.08$45.50 million$37.94 million    
5/3/2024Q1 2024
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
$0.17$0.19+$0.02$0.67$2.61 billion$2.61 billion    
2/29/202412/31/2023
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
-$0.09-$0.10-$0.01-$0.07$40.37 million$34.76 million    
2/28/2024Q3 2024
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
$0.60$0.59-$0.01$0.66$1.63 billion$1.62 billion      
2/20/202412/31/2023
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
$0.66$0.69+$0.03$1.15$2.67 billion$2.66 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
N/AN/AN/AN/AN/A
Galapagos NV stock logo
GLPG
Galapagos
N/AN/AN/AN/AN/A
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
N/AN/AN/AN/AN/A
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
$1.044.04%N/A51.23%N/A

Latest OMI, PDCO, GLPG, and DNA Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/11/2024
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
Quarterly$0.263.86%4/18/20244/19/20245/3/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
N/A
5.34
6.11
Galapagos NV stock logo
GLPG
Galapagos
N/A
9.91
9.70
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
2.17
1.16
0.56
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
0.46
1.43
0.72

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
78.63%
Galapagos NV stock logo
GLPG
Galapagos
32.46%
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
98.04%
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
85.43%

Insider Ownership

CompanyInsider Ownership
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
15.05%
Galapagos NV stock logo
GLPG
Galapagos
2.91%
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
3.59%
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
1.50%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
1,2182.15 billion1.83 billionOptionable
Galapagos NV stock logo
GLPG
Galapagos
1,12365.90 million63.98 millionOptionable
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
13,70076.50 million73.75 millionOptionable
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
7,60089.59 million88.25 millionOptionable

OMI, PDCO, GLPG, and DNA Headlines

Recent News About These Companies

Patterson sets sights on multiple state titles
Lia Patterson continues to break records at Tuscola

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Ginkgo Bioworks logo

Ginkgo Bioworks

NYSE:DNA
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Galapagos logo

Galapagos

NASDAQ:GLPG
Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667 that has completed phase 1b trial; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; GLPG5201, a CD19 CAR-T product candidates manufactured at point-of-care, currently in phase 1/2 trial in replapsed/refractory chronic lymphocytic leukemia; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc.; and AbbVie S.à r.l. Galapagos NV was incorporated in 1999 and is headquartered in Mechelen, Belgium.
Owens & Minor logo

Owens & Minor

NYSE:OMI
Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, including supplier management, analytics, inventory management, and clinical supply management; and various programs to provide outsourced logistics and marketing solutions to its suppliers. The Patient Direct segment provides products and services for in-home care and delivery across diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment. This segment supplies a range of other home medical equipment, patient care products, including ostomy, wound care, urology, incontinence and other products and services. It serves multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. Owens & Minor, Inc. was founded in 1882 and is headquartered in Richmond, Virginia.
Patterson Companies logo

Patterson Companies

NASDAQ:PDCO
Patterson Companies, Inc. engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems. It also provides a range of related services comprising software and design services, maintenance and repair, and equipment financing. The Animal Health segment distributes biologicals, pharmaceuticals, vaccines, parasiticides, diagnostics, prescription and non-prescription diets, nutritional's, consumable supplies, equipment, and software, as well as value-added services. This segment also provides private label portfolio of products to veterinarians, producers, and retailers under the Aspen, First Companion, and Patterson Veterinary brands. The Corporate segment offers customer financing services; and sells other miscellaneous products. It serves dentists, laboratories, institutions, other healthcare professionals, veterinarians, other animal health professionals, production animal operators, and animal health product retailers. The company was formerly known as Patterson Dental Company and changed its name to Patterson Companies, Inc. in June 2004. Patterson Companies, Inc. was founded in 1877 and is headquartered in Saint Paul, Minnesota.